Oryzon Genomics S.A. (ORYZF)
USD 3.03
(-0.66%)
USD 3.03
(-0.66%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 EUR | 22.91% |
| 2022 | -0.08 EUR | 14.98% |
| 2021 | -0.09 EUR | -37.89% |
| 2020 | -0.06 EUR | 21.18% |
| 2019 | -0.08 EUR | -166.99% |
| 2018 | -0.03 EUR | 80.88% |
| 2017 | -0.16 EUR | 20.0% |
| 2016 | -0.20 EUR | -454.02% |
| 2015 | -0.04 EUR | -115.7% |
| 2014 | 0.23 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.02 USD | 41.02% |
| 2024 Q2 | 0.00 EUR | 111.49% |
| 2024 Q3 | -0.02 EUR | -1190.0% |
| 2023 Q3 | -0.02 EUR | -191.04% |
| 2023 Q2 | 0.02 EUR | 168.14% |
| 2023 Q1 | -0.03 EUR | 29.59% |
| 2023 FY | - EUR | 22.91% |
| 2023 Q4 | -0.03 EUR | -61.2% |
| 2022 Q1 | -0.03 EUR | 13.64% |
| 2022 Q2 | 0.01 EUR | 118.13% |
| 2022 FY | - EUR | 14.98% |
| 2022 Q3 | -0.01 USD | -288.71% |
| 2022 Q4 | -0.04 EUR | -258.12% |
| 2021 Q2 | 0.02 EUR | 152.17% |
| 2021 FY | - EUR | -37.89% |
| 2021 Q3 | -0.03 USD | -266.67% |
| 2021 Q1 | -0.03 EUR | -60.47% |
| 2021 Q4 | -0.04 USD | -32.0% |
| 2020 Q2 | -0.00 EUR | 85.16% |
| 2020 FY | - EUR | 21.18% |
| 2020 Q4 | -0.02 EUR | -24.28% |
| 2020 Q3 | -0.02 EUR | -355.26% |
| 2020 Q1 | -0.03 EUR | -23.08% |
| 2019 Q2 | -0.01 EUR | 55.1% |
| 2019 Q1 | -0.03 EUR | -60.2% |
| 2019 Q4 | -0.02 EUR | 11.11% |
| 2019 FY | - EUR | -166.99% |
| 2019 Q3 | -0.02 EUR | -65.96% |
| 2018 FY | - EUR | 80.88% |
| 2018 Q2 | 0.05 EUR | 254.25% |
| 2018 Q3 | -0.03 EUR | -157.63% |
| 2018 Q4 | -0.02 EUR | 27.94% |
| 2018 Q1 | -0.03 EUR | 21.34% |
| 2017 Q4 | -0.04 EUR | -11.78% |
| 2017 Q2 | -0.04 EUR | 7.53% |
| 2017 Q1 | -0.05 EUR | 0.43% |
| 2017 FY | - EUR | 20.0% |
| 2017 Q3 | -0.03 EUR | 19.07% |
| 2016 Q2 | -0.07 EUR | -181.75% |
| 2016 FY | - EUR | -454.02% |
| 2016 Q1 | -0.03 EUR | -14.35% |
| 2016 Q4 | -0.05 EUR | 4.3% |
| 2016 Q3 | -0.05 EUR | 34.14% |
| 2015 Q3 | -0.01 EUR | -149.48% |
| 2015 Q4 | -0.02 EUR | -61.97% |
| 2015 FY | - EUR | -115.7% |
| 2015 Q1 | -0.03 EUR | 0.0% |
| 2015 Q2 | 0.03 EUR | 210.81% |
| 2014 FY | - EUR | 0.0% |